TRODELVY — IMMUNOMEDICS INC, approved 2026-06-24 (BLA761115).
4,611 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.